Re: "top line data on or before January 31, 2019" A Covenant of the loan
|
3
|
Resverlogix Corp.
|
Dec 19, 2018 08:44PM
|
Re: MD&A out
|
4
|
Resverlogix Corp.
|
Dec 15, 2018 06:09PM
|
Re: MD&A out
|
4
|
Resverlogix Corp.
|
Dec 15, 2018 02:45AM
|
Re: MD&A out
|
4
|
Resverlogix Corp.
|
Dec 14, 2018 03:40PM
|
Re: MD&A out
|
2
|
Resverlogix Corp.
|
Dec 14, 2018 02:45PM
|
Re: MD&A out
|
2
|
Resverlogix Corp.
|
Dec 14, 2018 01:36PM
|
Re: No love
|
4
|
Resverlogix Corp.
|
Dec 13, 2018 12:40PM
|
Re: Credit Suisse was the big seller....
|
4
|
Resverlogix Corp.
|
Dec 10, 2018 11:38PM
|
Re: Credit Suisse was the big seller....
|
3
|
Resverlogix Corp.
|
Dec 10, 2018 06:06PM
|
Re: Credit Suisse was the big seller....
|
4
|
Resverlogix Corp.
|
Dec 10, 2018 04:52PM
|
Re: Over 65K in the first hour of trading...
|
5
|
Resverlogix Corp.
|
Dec 10, 2018 01:25PM
|
Re: The runway is clear....
|
5
|
Resverlogix Corp.
|
Dec 08, 2018 04:09PM
|
Re: The runway is clear....
|
5
|
Resverlogix Corp.
|
Dec 08, 2018 03:02PM
|
Re: Top-line vs. Full Detailed Clinical Trial Results
|
2
|
Resverlogix Corp.
|
Dec 08, 2018 12:40AM
|
Re: Top-line vs. Full Detailed Clinical Trial Results
|
2
|
Resverlogix Corp.
|
Dec 07, 2018 05:13PM
|
Re: The runway is clear....
|
8
|
Resverlogix Corp.
|
Dec 06, 2018 01:05PM
|
Re: Are statins overprescribed? Why the risks and benefits are so complex
|
4
|
Resverlogix Corp.
|
Dec 04, 2018 11:32PM
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
4
|
Resverlogix Corp.
|
Dec 03, 2018 08:40PM
|
Re: Patient Enrollment Modeling
|
5
|
Resverlogix Corp.
|
Dec 02, 2018 12:58PM
|
Re: Pointing in the right direction & bogus Lilly
|
5
|
Resverlogix Corp.
|
Dec 01, 2018 02:59PM
|